In this paper the authors quantify hepatitis C disclosure outcomes across social contexts and identify the factors associated with widespread disclosure of infection. In a cross-sectional survey of people with hepatitis C (N = 504) more than half reported receiving a bad reaction from someone following disclosure. Unauthorized disclosure occurred, and many participants had been pressured into disclosing their infection. The factors associated with widespread disclosure were: education level; knowing other people with hepatitis C; feeling fatigued; receiving disclosure advice; and experiencing unauthorized disclosure. Bad reactions following disclosure are common and may impede health-seeking behaviour including uptake of hepatitis C treatment.
Anti-Discrimination Board of New South Wales. ( 2001). C-Change: Report of the enquiry into hepatitis C-related discrimination. Sydney: Anti-Discrimination Board of New South Wales.
2.
Ariss, R.M. ( 1997). Against death: The practice of living with AIDS. Amsterdam BV: Gordon & Breach Publishers.
3.
Australian National Council on AIDS, Hepatitis C and Related Diseases (ANCHARD) and the Hepatitis C Virus Projections Working Group Hepatitis C SubCommittee. (2002). Estimates and projections of the hepatitis C virus epidemic in Australia. Sydney : National Centre in HIV Epidemiology and Clinical Research, UNSW.
4.
Crofts, N., Louie, R., & Loff, B. ( 1997). The next plague: Stigmatisation and discrimination related to hepatitis C virus infection in Australia. Health and Human Rights, 2, 86-97.
5.
Dunne, E.A., & Quayle, E. ( 2002). Pattern and process in disclosure of health status by women with iatrogenically acquired hepatitis C. Journal of Health Psychology, 7, 565-582.
6.
Fraser, S., & Treloar, C. ( 2006). ‘Spoiled identity’ in hepatitis C infection: The binary logic of despair. Critical Public Health, 16, 99-110.
7.
Gifford, S.M., O’Brien, M.L., Bammer, G., Bamwell, C., & Stoove, M. ( 2003). Australian women’s experiences of living with hepatitis C virus: Results from a cross-sectional survey. Journal of Gastroenterology and Hepatology, 18, 841-850.
8.
Golden, J., Conroy, R.M., O’Dwyer, A.M., Golden, D., & Hardouine, J.B. (2006). Illness-related stigma, mood and adjustment to illness in persons with hepatitis C. Social Science and Medicine, 63, 3188-3198.
9.
Gyarmathy, A.V., Neaigus, A., Ujhelyi, E., Szabo, T., & Racz, J. ( 2006). Strong HIV and hepatitis disclosure norms and frequent behaviors among Hungarian drug injectors. Drug and Alcohol Dependence, 82 (Suppl. 1), S65-S69.
10.
Hepworth, J., & Krug, G.J. ( 1999). A socio-cultural perspective on the effects of a new virus on a community’s health. Journal of Health Psychology , 4, 237-246.
11.
Holt, R., Court, P., Vedhara, K., Nott, K.H., Holmes, J., & Snow, M.H. ( 1998). The role of disclosure in coping with HIV infection. AIDS Care, 10, 49-60.
12.
Hopwood, M., & Treloar, C. ( 2008). Applying adaptive responses to prior adversity during treatment for hepatitis C infection. Journal of Health Psychology , 13, 17-27.
13.
Hopwood, M., Treloar, C., & Bryant, J. ( 2006). Hepatitis C and injecting-related discrimination in New South Wales, Australia. Drugs: Education, Prevention and Policy , 13, 61-75.
14.
Hopwood, M., Treloar, C., & Redsull, L. ( 2006). Experiences of hepatitis C treatment and its management: What some patients and health professionals say [Monograph 4/2006]. Sydney: National Centre in HIV Social Research, UNSW .
15.
Kennamer, J.D., Honnold, J., Bradford, J., & Hendricks, M. ( 2000). Differences in disclosure of sexuality among African American and white gay/bisexual men: Implications for HIV/AIDS prevention . AIDS Education and Prevention, 12, 519-531.
16.
Malcolm, A., Aggleton, P., Bronfman, M., Galvao, J., Mane, P., & Verrall, J. ( 1998). HIV-related stigmatisation and discrimination: Its forms and contexts. Critical Public Health, 8, 347-370.
17.
McPherson, M., Smith-Lovin, L., & Cook, J.M. ( 2001). Birds of a feather: Homophily in social networks [Review] . Annual Review of Sociology, 27, 415-444.
18.
National Centre in HIV Epidemiology and Clinical Research. ( 2008). HIV/AIDS, viral hepatitis and sexually transmissible infections in Australia. Annual Surveillance Report2008. Sydney: National Centre in HIV Epidemiology and Clinical Research.
19.
National Centre in HIV Social Research (NCHSR). (2001). An epidemic of difference: A social analysis of hepatitis C-related discrimination. (Appendix E; by M. Hopwood & S. Kippax). In C-Change: Report of the enquiry into hepatitis C-related discrimination. Sydney: Anti-Discrimination Board of New South Wales .
20.
Owens, G. ( 2008). An ‘elephant in the room’? Stigma and hepatitis C transmission among HIV-positive ‘serosorting’ gay men. Culture, Health and Sexuality, 10, 601-610.
21.
Paterson B.L., Backmund, M., Hirsch, G., & Yim, C. ( 2007). The depiction of stigmatization in research about hepatitis C. [Review]International Journal of Drug Policy, 18, 364-373.
22.
Pennebaker, J.W. ( 1995). Emotion, disclosure and health. Washington, DC: American Psychological Association.
23.
Platt, M.W., & Gifford, S.M. ( 2003). Promoting health through promoting work: The dilemmas of disclosure in the workplace for employers and for Australian women living with hepatitis C. Health Promotion Journal of Australia, 14, 180-186.
24.
Schafer, A., Scheurlen, M., Felten, M., & Kraus, M.R. ( 2005). Physician-patient relationship and disclosure behaviour in chronic hepatitis C in a group of German outpatients. European Journal of Gastroenterology and Hepatology, 17, 1387-1394.
25.
Serovich, J.M. ( 2001). A test of two HIV disclosure theories. AIDS Education and Prevention, 13, 355-364.
26.
Treloar, C., & Hopwood, M. ( 2004). Infection control in the context of hepatitis C disclosure: Implications for education of healthcare professionals. Education for Health, 17, 183-191.
